Use access key #2 to skip to page content.
$7.93 0.27 (3.52%)
7/8/2008 4:00 PM

Regeneration Technologies, Inc. (RTIX)

CAPS Rating:
****

The Company uses natural tissues and innovative technologies to produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.

X

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating RTIX

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

73 Outperforms
6 Underperforms
 

All-Stars

20 Outperforms
3 Underperforms
 

Wall Street

7 Outperforms
0 Underperforms
 

Players bullish on RTIX are also bullish on:

Players bearish on RTIX are also bearish on:

Ticker Tags

Micro Cap (4824), Biotechnology (293), Equipment (65), Medical Appliances & Equipment (106)
Suggest a tag

Regeneration Technologies, Inc. At A Glance

Current Price: $7.93
Last Trade Time: 7/8/2008 4:00 PM
Open: $7.70
Previous Close: $7.66
Daily Range: $7.61 - $7.93
52-Week Range: $7.02 - $11.99
Volume: 627,924
Market Cap: $417.92M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

RTIX VS S&P 500 (SPY)

RTIX 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for RTIX

More Headlines...

Top Bull Pitch

Recs

1

Regeneration Technologies, Inc. (RTIX)

Avatar umguy08 (< 20) Submitted: 4/13/07 6:22 PM

Strong pipeline of products thats unmatched by any competitor. Only company seriously developing bovine material into a safe, cheap and reliable product platform. Only company with FDA approved Biocleanse process. Lots of possible future growth and expansion (international..ect.)

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Regeneration Technologies, Inc. (RTIX)

Avatar farmerellis (99.89) Submitted: 7/12/07 12:20 AM

As far as I can tell, this is a great company. However, it is way to expensive right now. Its an easy short for points down somewhere in the 9.50 range. I'll probably remove it after the correction.

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 11 :   1 2 3 Next »

Recs

0

 (RTIX)

Avatar mdriver78 (< 20) Submitted: 6/09/08 4:04 AM : Outperform Start Price: $10.12 RTIX Score: -14.45

The revenues, earnings and margins are growing and in the hightlights from the most recent quarter reveals a great story for a future of long term growth:





- Successful completion of merger with Tutogen to form RTI Biologics


- Reported gross margins of 47 percent before purchase accounting adjustments related to merger with Tutogen – a year-over-year improvement of 1000 basis points and a sequential gain of 300 basis points from the fourth quarter 2007


- Achieved record sports medicine revenues, increasing by 71 percent over the first quarter 2007


- Delivered initial shipment of Puros® allograft bone paste to Zimmer Inc.


- Launched fresh-stored osteochondral allograft line at the American Academy of Orthopaedic Surgeons (AAOS)





As a result of the Tutogen merger, revenues in 2008 include the new lines of business for dental and surgical specialties, as well as additional international distribution originating from the German facility.





Further, the Co announced the successful implantation of its first fresh-stored osteochondral (OC) allograft in Arkansas in Mid June 08.





The female patient, 40, with a history of persistent knee pain due to articular cartilage damage, underwent a microfracture procedure approximately one year ago, but the lesion persisted. The fresh-stored OC allograft allowed the surgeon to resurface the defect with mature hyaline cartilage, while providing the patient with a smooth articulating surface.





This Co is in the early stages of profitability and the successful merging of newly acquired business shows a sound management team with a good eye for value added strategies going forward.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RTIX)

Avatar enodlo (< 20) Submitted: 5/07/08 2:51 PM : Outperform Start Price: $10.04 RTIX Score: -11.96

Pending research limitations the breakthroughs in their feild will be plentiful. Stem cell stimulation of tutoplasty is the next step.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RTIX)

Avatar kenny928 (52.76) Submitted: 3/05/08 12:11 PM : Outperform Start Price: $10.01 RTIX Score: -15.52

Starter

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RTIX)

Avatar TrackMasterTrack (97.98) Submitted: 1/01/08 3:00 PM : Outperform Start Price: $8.70 RTIX Score: 4.34

my speculation genie whispers that companies that
insurance companies like will be hot. and perhaps that their stocks will get the hype and hysteria too.... also I am watching and have profited from ISRG.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RTIX)

Avatar trajan24 (25.56) Submitted: 8/12/07 5:30 AM : Outperform Start Price: $11.44 RTIX Score: -17.51

Good products

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 11 :   1 2 3 Next »

Wall Street

Results 1 - 7 of 7  

picks per page. CHANGE

Top
Pick		Player NamePlayer RatingStart
Date		CallTime FrameStart
Price		Stock
Gain		S&P
Gain		ScorePitch
TrackJesupLamont 43.90 06/20/08 Outperform NS $8.99-11.79%-4.34%-7.45
TrackPacificGrow 56.32 03/20/08 Outperform NS $8.30-4.46%-2.19%-2.27
TrackCollinsStew < 20 02/07/08 Outperform NS $8.59-7.68%-3.49%-4.19
TrackBofASec 97.11 12/10/07 Outperform NS $9.26-14.36%-15.92%+1.55
TrackSusquehanna < 20 11/19/07 Outperform NS $9.50-16.53%-12.44%-4.08
TrackSunTrustRH 81.35 04/05/07 Outperform NS $7.74+2.45%-11.46%+13.92
TrackWRHambrecht < 20 04/04/07 Outperform NS $7.41+7.02%-11.48%+18.49

Results 1 - 7 of 7  

X

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners